FRANKLIN LAKES, N.J., Feb. 16, 2011 /PRNewswire/ -- Industrial microbiologists now have a new tool that was designed specifically to help quality control laboratories rapidly screen raw materials, as well as in-process and finished goods, for the presence of microorganisms that can threaten product quality.
BD Biosciences and BD Diagnostics, two business segments of BD (Becton, Dickinson and Company) (BDX), a leading global medical technology company, announced today the addition of the new BD FACSMicroCount flow cytometry system to the Company's industrial microbiology portfolio. BD obtained worldwide rights from Advanced Analytical Technologies to market the instrument, which was previously known as the Micro PRO Microbial Detection System.
"Acquiring this new platform allows us to draw upon expertise from across the Company," said James Glasscock, President of Cell Analysis, BD Biosciences. "It will allow us to leverage our collective expertise in industrial microbiology quality control and flow cytometry to benefit our customers."
This BD FACSMicroCount system is especially suited for makers of pharmaceuticals, personal care products, beverages, probiotics, and home cleaning products, as well as water treatment facilities It screens for a variety of microorganisms including bacteria, yeast, mold, spirochetes, Mycoplasma, and parasite cysts. The system reduces the time to result and automates traditional methods, helping to reduce production cycles and achieve cost savings, especially in labor, inventory and warehouse costs.
"Adding this instrument to our portfolio supports BD's growth-through-innovation strategy and reinforces our position as a leader in industrial microbiology by offering customers the widest choice of microbial detection platforms," said Tom Polen, President, BD Diagnostics. "While complementing our existing microbiology media and PCR products, this new system satisf
|SOURCE BD-Becton Dickinson|
Copyright©2010 PR Newswire.
All rights reserved